[Consensus document on the clinical use of melatonin in children and adolescents with sleep-onset insomnia.]

Anales de pediatria (Barcelona, Spain : 2003)

PubMedID: 24768501

Pin Arboledas G, Merino Andreu M, de la Calle Cabrera T, Hidalgo Vicario MI, Rodríguez Hernández PJ, Soto Insuga V, Madrid Pérez JA. [Consensus document on the clinical use of melatonin in children and adolescents with sleep-onset insomnia.]. An Pediatr (Barc). 2014;.
Sleep problems are highly prevalent among our children and adolescents. Its treatment is mainly based on cognitive behavioural therapies and habit modification procedures. However, the use of sleep promoting drugs and substances is widespread without being supported by clinical guidelines. Exogenous melatonin is a neurohormone marketed as a nutritional supplement that is being increasingly used in the management of sleep problems, and with no control over its use. The consensus document is presented on the use of melatonin in sleep-onset insomnia prepared by representatives of the Spanish Paediatric Association, the Spanish Society of Sleep, the Spanish Society of Paediatric Outpatients and Primary Care, the Spanish Society for Adolescent Medicine, the Spanish Society of Child Psychiatry, and the Spanish Society of Paediatric Neurology.